Annual Gross Profit
$263.71 M
+$190.65 M+260.92%
December 31, 2024
Summary
- As of March 10, 2025, ESPR annual gross profit is $263.71 million, with the most recent change of +$190.65 million (+260.92%) on December 31, 2024.
- During the last 3 years, ESPR annual gross profit has risen by +$199.48 million (+310.58%).
- ESPR annual gross profit is now at all-time high.
Performance
ESPR Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$43.48 M
+$9.14 M+26.60%
December 1, 2024
Summary
- As of March 10, 2025, ESPR quarterly gross profit is $43.48 million, with the most recent change of +$9.14 million (+26.60%) on December 1, 2024.
- Over the past year, ESPR quarterly gross profit has dropped by -$14.74 million (-25.32%).
- ESPR quarterly gross profit is now -79.47% below its all-time high of $211.84 million, reached on June 30, 2020.
Performance
ESPR Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$263.71 M
+$22.68 M+9.41%
December 1, 2024
Summary
- As of March 10, 2025, ESPR TTM gross profit is $263.71 million, with the most recent change of +$22.68 million (+9.41%) on December 1, 2024.
- Over the past year, ESPR TTM gross profit has increased by +$36.44 million (+16.03%).
- ESPR TTM gross profit is now at all-time high.
Performance
ESPR TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
ESPR Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +260.9% | -25.3% | +16.0% |
| 3 y3 years | +310.6% | -25.3% | +16.0% |
| 5 y5 years | +77.8% | +4327.9% | +77.8% |
ESPR Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +443.6% | -65.9% | +349.9% | at high | +550.3% |
| 5 y | 5-year | at high | +443.6% | -79.5% | +4327.9% | at high | +5447.2% |
| alltime | all time | at high | >+9999.0% | -79.5% | +4332.4% | at high | +5447.2% |
Esperion Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $263.71 M(+260.9%) | - | - |
| Dec 2024 | - | $43.48 M(+26.6%) | $263.71 M(+9.4%) |
| Sep 2024 | - | $34.35 M(-41.0%) | $241.03 M(+6.1%) |
| Jun 2024 | - | $58.23 M(-54.4%) | $227.28 M(+20.9%) |
| Mar 2024 | - | $127.66 M(+513.8%) | $188.05 M(+157.4%) |
| Dec 2023 | $73.07 M(+50.6%) | $20.80 M(+1.0%) | $73.07 M(+9.2%) |
| Sep 2023 | - | $20.59 M(+8.4%) | $66.93 M(+13.8%) |
| Jun 2023 | - | $19.00 M(+49.9%) | $58.81 M(+18.9%) |
| Mar 2023 | - | $12.68 M(-13.5%) | $49.47 M(+2.0%) |
| Dec 2022 | $48.51 M(-24.5%) | $14.66 M(+17.5%) | $48.51 M(+9.8%) |
| Sep 2022 | - | $12.47 M(+29.1%) | $44.18 M(+8.9%) |
| Jun 2022 | - | $9.66 M(-17.5%) | $40.55 M(-41.9%) |
| Mar 2022 | - | $11.71 M(+13.4%) | $69.75 M(+8.6%) |
| Dec 2021 | $64.23 M | $10.33 M(+16.7%) | $64.23 M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $8.85 M(-77.2%) | $61.85 M(+9.4%) |
| Jun 2021 | - | $38.86 M(+527.4%) | $56.56 M(-75.4%) |
| Mar 2021 | - | $6.19 M(-22.1%) | $229.54 M(+1.9%) |
| Dec 2020 | $225.16 M(+51.8%) | $7.95 M(+123.4%) | $225.16 M(+3.2%) |
| Sep 2020 | - | $3.56 M(-98.3%) | $218.19 M(+1.2%) |
| Jun 2020 | - | $211.84 M(>+9900.0%) | $215.61 M(+4435.3%) |
| Mar 2020 | - | $1.81 M(+84.2%) | $4.75 M(-96.8%) |
| Dec 2019 | $148.36 M(>+9900.0%) | $982.00 K(+0.1%) | $148.36 M(+0.7%) |
| Sep 2019 | - | $981.00 K(-0.1%) | $147.38 M(+0.7%) |
| Jun 2019 | - | $982.00 K(-99.3%) | $146.40 M(+0.7%) |
| Mar 2019 | - | $145.42 M | $145.42 M |
| Dec 2018 | $0.00(-100.0%) | - | - |
| Dec 2000 | -$784.00 K(+15.0%) | - | - |
| Dec 1999 | -$682.00 K | - | - |
FAQ
- What is Esperion Therapeutics annual gross profit?
- What is the all time high annual gross profit for Esperion Therapeutics?
- What is Esperion Therapeutics annual gross profit year-on-year change?
- What is Esperion Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly gross profit year-on-year change?
- What is Esperion Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Esperion Therapeutics?
- What is Esperion Therapeutics TTM gross profit year-on-year change?
What is Esperion Therapeutics annual gross profit?
The current annual gross profit of ESPR is $263.71 M
What is the all time high annual gross profit for Esperion Therapeutics?
Esperion Therapeutics all-time high annual gross profit is $263.71 M
What is Esperion Therapeutics annual gross profit year-on-year change?
Over the past year, ESPR annual gross profit has changed by +$190.65 M (+260.92%)
What is Esperion Therapeutics quarterly gross profit?
The current quarterly gross profit of ESPR is $43.48 M
What is the all time high quarterly gross profit for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly gross profit is $211.84 M
What is Esperion Therapeutics quarterly gross profit year-on-year change?
Over the past year, ESPR quarterly gross profit has changed by -$14.74 M (-25.32%)
What is Esperion Therapeutics TTM gross profit?
The current TTM gross profit of ESPR is $263.71 M
What is the all time high TTM gross profit for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM gross profit is $263.71 M
What is Esperion Therapeutics TTM gross profit year-on-year change?
Over the past year, ESPR TTM gross profit has changed by +$36.44 M (+16.03%)